2 unknown, 1 completed. 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 2 |
| Phase 1 | 1 | Completed 1 |
Follow Lead-201: new trials by email Literature Review of Lead-201 trials Research Report on Lead-201
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Efficacy and Safety of PB-201 in Type 2 Diabetic Mellitus Patients With Poor Glycemic Control Via Metformin Hydrochloride Monotherapy PB-201, PB-201 matched placebo, Metformin hydrochloride - Type 2 Diabetes Mellitus | Phase 3 | Unknown | PegBio Co., Ltd. | 546 | 2022-05-30 | 2022-04-22 |
| Study to Evaluate the Safety and Efficacy of PB-201 in Treatment-naive Patients With Type 2 Diabetes Mellitus PB-201, Vildagliptin, PB-201 matched placebo - Type 2 Diabetes Mellitus (T2DM) | Phase 3 | Unknown | PegBio Co., Ltd. | 672 | 2021-09-30 | 2022-02-08 |
| Clinical Trial for the Investigational Drug (PB-201) in Subjects With Type 2 Diabetes Mellitus glucokinase activator, Placebo - Type2 Diabetes Mellitus | Phase 1 | Completed | PegBio Co., Ltd. | 16 | 2019-08-27 | 2020-01-22 |
Diabetes Mellitus, Type 2 (2) · Hypoglycemia (1)
PegBio Co., Ltd. (3)
China (3) · Hong Kong (1) · Taiwan (1)
HaiYan Li (1) · Linong Ji, MD,PhD (1)